Loading chart…
CLOSED
Brooks Laboratories Limited operates as a pharmaceutical manufacturer in India and internationally. It operates in two segments, Manufacturing and Trading. The company offers liquid injection ampoules and vials, dry powder injection vials, lyophilized injections, eye/ear drops, and nasal drops; and B-Lactam and cephalosporin tablets, dry powder syrups, and injections.
Brooks Laboratories Limited (BROOKS) is listed on the NSE in the Healthcare sector, Drug Manufacturers - Specialty & Generic industry. The BROOKS share price is ₹66.19 (+4.65% today), with a market capitalisation of ₹2B and a price-to-earnings (P/E) ratio of 15.4. MarketRipple tracks the BROOKS investment thesis, the ripple-chain impact of market events on Brooks Laboratories Limited, and the Healthcare sector outlook.
Open
₹67.90
High
₹68.90
Low
₹65.25
Prev. Close
₹63.25
52W High
₹112.40
52W Low
₹36.30
Day range
₹65.25–₹68.90
52-week range
₹36.30–₹112.40
Volume
14K
P/E
15.4
ROE
20.0%
D/E
0.07
Margin
15.9%
Brooks Laboratories Limited (NSE: BROOKS) is currently trading at ₹66.19 (+4.65%).
Brooks Laboratories Limited's market capitalization is ₹2B.
Brooks Laboratories Limited's price-to-earnings (P/E) ratio is 15.4.
Brooks Laboratories Limited operates in the Healthcare sector (Drug Manufacturers - Specialty & Generic).